<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="257" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/257?output=omeka-xml" accessDate="2026-06-07T21:18:39+00:00">
  <fileContainer>
    <file fileId="48">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/f8b5cf3cf6b847561379d21a8181ceef.pdf</src>
      <authentication>550c4683b921dafa008583e1e9dd5aff</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="100674">
                  <text>��COPY

Clinical Release
PRODUCT

Combination of 'Thorazine' and Diparcol (SKF #1026-A)

Diparcol alone

'Thorazine'

mg/cag.

ca .

FORMULAS

50.0 mg.

H01

2.0

Magnesium.Stearate
Lactose

200.0

-__-

----

mg.
mg.

300.0 mg.

is.
Restricted Medical Utility Studies - Dr.

Herman Denber

TOXICITY

Acute Intravenous Toxicity The intravenous acute toxicity of a combination of
SKF #1026—A ('Diparcol') and 'Thorazine' in the ratio of 5:1 was determined.
Intravenous LD50'S in male mice (CFl) were determined for SKF #1026-A, 'Thorazine'
and a combination of SKF #1026-A and ‘Thorazine' in the ratio of 5:1. The mice
were observed for a 2h hour period, at which time all surviving mice appeared
—

normal.

Combination

significantly

more

toxic than

SKF #1026-A

(T.R.

=

1.2)

'Thorazine' ngt_significantly'more toxic than combination.

(T.R.

'Thorazine' significantly more toxic than

- 1.36)

SKF

#1026-A (T.R.

=

1.13)

acute intravenous toxicity in mice of a combination of 'Thorazine' and
‘Diparcol', in the ratio of 1 part of 'Thorazine' to 5 parts of 'Diparcol',
did not differ significantly from that of 'Thorazine' alone. Such a comparison
is valid since the slopes of the toxicity curves are parallel. The combination
is significantly more toxic than 'Diparcol' alone, but the comparison is subject
to criticism.that the slopes of the toxicity curves are not parallel.

The

December 9, 1955

�DIPARCOL

In answer to your request an attempt has been made to find data comparing the
anticonvulsant activity of Diparcol (Diethazine, SKF #1026) with.that of other
phenothiazine derivatives: Phenergan (SKF 1&amp;98), 'Thorazine‘ (SKF 2601),

Promazine (SKF 3h06), 'Compazine' (SKF h657), SKF 5277 and SKF 5116. No such
studies have been done in our laboratory. The only SKF lab report on Diparcol
gives its toxicity as LDSO * 31.2 mg/Kg I.V. as compared with 22.9 mg/Kg I.V.

for 'Thorazine'.

Balestrieri

(1955) compared Diethazine, Phenergan, Parsidol and chlorpromazine
with respect to their protective action against electroshock and Metrazol
seizures in rabbits. Phenergan and chlorpromazine showed no anticonvulsant

action against electroshock seizures; Diethazine, 5 mg/Kg I.V. protected
2/5 animals and at 10 mg/Kg I.V. 3/5 animals. Parsidol protected 2/5 animals
at both doses. These results confirm SKF data obtained using maximal electroshock seizures in mice which showed no anticonvulsant activity for SKF lh98,
2601, h657 or 5116. SKF 3h06 did protect mice against seizures; the ED§Q was
155 mg/Kg p.o. SKF 5277 also demonstrated anticonvulsant activity with an
oral ED50 of 71.0 mg/Kg.
,

Balestrieri

snowed chlorpromazine to be
Metrazol seizures. Phenergan was inactive

inactive in protecting
at 5 mg/Kg I.V.
rabbits against
but a 10 mg/kg I.V. protected h/5 animals. Diethazine protected h/5 animals
at 5 mg/Kg and 5/5 at 10 mg/kg. ParSidol protected 5/5 animals at both doses.
’No similar SKF data are available.
The experiments of

Anticonvulsant action and molecular structure of phenothiazine
derivatives. .krch. Int. Pharmacodynam. 103:1-11, 1955

Balestrieri,

HLM:pz

hc

A.

�COPY-

PHARMACOLOGY REPORT

November 8, 1956

10-(2'-Diethy1aminoethyl)-Phenothiazine
Hydrochloride 0R (Diparcol)

SKF No. 1026-A

Compound:

Code No. Lot No. 99

Structure:

)W
ii

/”
'\\
K\//h\§v/\
EV

1

9H2
l

c H2.N-( 02H37~2

mignzim.R.T.Cmma'
Tested for:

Dose Range

-

.HCl

Mmda

Studies in mice after intravenous administration (11/10/55)

Observations

Dose
rug/kg

side effects

2.5

No

5.0

2/2 slight depression, loss of pinnal reflex
2/2 ataxia, sl. depression, loss of pinnal reflex, 'Thorazine'
walk.
2/2 ataxia, marked depression, dyspnea, 'Thorazine' walk,
loss of pinnal reflex.

10.0

15.0

6/6 clonic convulsions, apnea, prostration, ataxia after recovery, hypotonicity, 3/6 dead
2/2 clonic convulsions, apnea, prostration, ataxia after re-

20.0

25.0

.

cover

h

otonicit

Note-—all animals recovered from.prostration within 60 minutes..
Summary:

exhibited 'Thorazine'-like side effects after intravenous
administration in mice. Slightly higher doses were required to produce
depression than with 'Thorazine' and the depression produced was of
shorter duration.

SKF #1026—A

'Thorazine'-like

Activity:
Charge:

Biological screening

GW/IB/m/mh

�LILLY LABORATORY FOR CLINICAL RESEARCH
INDIANAPOLIS GENERAL HOSPITAL

INDIANAPOLIS

7, U.

S.A.

December 29, 1955

Max

Fink,

MOD.

Hillside Hospital
75-59 263rd Street

Glen Cake,

New

York

Dear Dr. Fink:

In answer to your recent request, Storey et a1. (Antibiotic
Med. &amp; Clin. Therapy, 2c258, September, I§§STI though
they do not report electroencephalogram findings, do
discuss the behavioral effects of cycloserine. There
have been no publications, to my knowledge, reporting
EEG findings in patients receiving 'Seromycin' (Cycloserine,

Lilly).

Veterans Administration hospitals have been doing
EEG tracings but their reports have not yet been published.
They will probably present their data at the Veterans
Administration Conference on the Chemotherapy of Tuberculosis
to be held in St. Louis in February.
do
be
not
we
of
further
please
may
assistance,
any
If
hesitate to w rite us.
The

Very

truly yours,

f th, M.D.
ri
Clinical esearch Division

R.
mlw

18760EIGHTIETH ANNIVERSARY-1956

�TELEPHONE: LEHIBH

Form 90a-Adm.

4-1300

State of New York
Department of Mental Hygiene
MANHATTAN STATE HOSPITAL

JOHN H. TRAVIS, M. D.
DIRECTOR

IN

Ward’s Island, New York City 35, N. Y.

ANSWERING REFER To

______.______._____

Dr. Max Fink

June 20, 1957

Hillside Hospital
75-59 263rd Street

Glen Oaks, N. Y.
Dear Max:

your findings on
I should like very much to include
Chloram
on
I
that
writing
the
final
in
paper
the 'Diparcol'
me
send
Could
of
you
Treatment
Depression.
promazine-Diethazine
diethazine
I.V.
of
the
effects
in
general,
note
indicating,
a brief
on the EEG? Were there any concomitant psychological effects?
of
"personal
reference
under
the
of
note
I will
course,
this,
communication."
Many

thanks.
Sincerely yours,

[/7
HD:SS

Herman C. B. Denber, M. D.

Director of Psychiatric Research

�4;:-

x}

June a?) 1957.

Dr.

Hem 6.

B. Ember,

Dimmr of Payehiatma Bsmmh,
Mahatma; State ammm,
”55W"! 1818M, ”at.
f:

,

Dear Hm

Itwaaaplmto
Atlantic city. I am aomr that

mm
we

We

withyouandymwﬁein
mum
could not. get. smother for "mucus“

much.
Johanna
and
cmvisit.
I
social
enjoyed
bht
very
Mb:
5.3
who:
moth
with
a wry Might. boy, But this yw' almdy
may:
Mahala,
Ina
1mm. A9 fer our “parlance with
your suggestion in
1 obtained some intmous manual from SKI. In the last 1w
‘mths we hm given it. to six ”news intmmly. Evin subject and
tt. {um
at" electroshock therapy and the trim of the
I.
of
much. In sank instance high
height. of m:
mo
1n
In: an
the
premix
"mag
abatmmphdogm
u’mrity
tam.
the
but situation, in which I and an we qmamm
3 and than remand
after the
parlour M the Watt-attests cf the d
50
2
of
the
The
rate
was
mm.
dosage
drug
gvmat
smnmum.
and
than
abuut
for
thirty
”cording
a
at.
of
the
air.
rate
mast
how
the
to
for
eight
Manama unplug
:pprmntnly mm hour.

mm. mm

mm,

W

93.03th

m
m mm

W» 6!me

We:

m.
mum

WW m
W
m

ma

Way m

hiring the ministmtion, each patient Moped, batman the
coma um fourth cc. m epdseda of waging. mare m
macaw
in breathing which an trunnion. This was the mat untoward attach a:

m

m

alaotromcophnlosnphia ohms pared gradually but was mt.
M:
the:
tho
of
minutes
n
injection.
within
tan 150 ace
mm
apparent.
to
thin tin mm
veto mead rm a may a!
than
mansions
70
rum
rmmyms
toammcf

in
mm»

Wt.-

mmumm.
tamper-u
MWalimdzm;wnwegemmWofﬁmSma
cent. tin 691th, however, mad about the sum. Mb 3:: «that peanut!
far one to an hours and in :1]. WWW 1n the maples “loan about four to
time: hours liter the Gilt: activity at at the pro-injection m1. In an.
“outpatient:mdauutiﬂtymmotthaomrofhto66330.3“
caploﬁon of the Winn
in value” of he to 70 UN. mm
the delta activity am: ”My ma in pomnt tiny and in voltage u:
that. m an: amount! mam- him he Waits. nun appeand stupor-impound
ﬁlm

�Dr»

new

at

Bar

mr,

#2

a clearly defined 25 cpl. nativity...
Tlmm
records
the
the
was an ”alerting?
following.
report
Warmly
animated by an incmaad methane” ai‘ we patient and a
crust. “ibis
greater difficulty in having the patient maintain his eyes gazed, ma
tbs change in hm patients from: a
"Home for this alerting phenm
effect to a mgative am)... The changes in language after
positive
were the reverse of the changes in language which we have axperlmcod
131ml
1n the past after tho amatmtion a! mama-him. Since we use the identical
w scone the changes in 11am in an Mammal fashion. In
maimaim,
three Mamas the questions prior to the
of Dime}. wen
11-.
and
therefore
to ovum.“ the changes in Imam.
negative
Waible
&amp; “manure"
In one manna tha max-d changed
in
to
an
1mm.
mama
clung» of the kind tkmt we see: with mbarbim. This dinmponcy
I. cannot explain.

m

m

m1

m

1mm

W10

rm

manna;

am eontinning this study and I would 11m to pmmt the behavioral
and electroeneephalog‘aphia effects My in the £111 to the Eastern EEG
Association. Thaw observations are, of eourse, migratory and I am not 8m 8 UT
the next batch or patients may not shot-7 us some other patterns. To tho
ﬂat
extent. that. this inmatigation has confirmed the observations of Leann”, I
an moat yieased.
Ha

I

have no objection to war reporting some of this itﬂ'omtian in
outline. If
is of any help ta you, I will be pleased to see the paragraph:
as yen intend to report, them and give you my reaction as to how they reflect.

it

our axpoziemaa,

Sincerely yours,Kn: Fink,

Dani-haunt at
MFtJB

mammal Pnyuhiatry.

H.130

�“,f
‘i? ziirect
i
v

.

i

of Diethazine on

EEG

’5‘
0+3

qt

I

for

and Significance

Theory of

Convulsive Therapy

Mauougﬂwk.ﬂdb
Previous studies of the role of

EEG

changes

in convulsive therapy
delta activity for

have demonstrated the significance of the induced

the behavioral re3ponse. Investigations concerning the biochemical

substrate of

delta in electroShock and convulsions

EEG

have indicated

significance for the cholinesterase - acetylcholine system.

reports
on

by

Ulett concerning the effects of atropine and

Recent

00’
scogﬁlﬂhine

the delta response-efﬁhe-EEE-showed a reversal of the-induced

patterns. Boncurrent

iswmvaﬁ.
reports by
r and

of diethazine on normal

EEG

and

that following

Lechner on the

EEQ

effects

trauma provided the

stimulus for the study of the effects of this drug in electroshock.

Subjects:
Twenty

voluntary

psychiatric patient in an openyward/psychiatric hospital

have been tested to date.

d

"

£5?
During
recording,

at various

maturing

(Biparcol)

is administred intravenously at

per minuteI

Maw
“'5’57- £155;
xi

treatmen .

rmi

94°"

"

the rate of 25 milligrams

‘1 250 milligrams,

{My

diethazime

70.,qu

*

�Observations :

a)

by
the
of
All
dryness
cmgling,
respond
subjects
Behavioral“
mouth and

thickness of speech. Feelings of weakness of extremities

illusory sensations are

and

There

common.

is

an increase

in rest-

lessness and difficulty in maintaining eyes closed. In patients
who have had

sufficient electroshock to manifest syntactic

and

orientation language changes indicative of altered cerebral function,

is

there
‘

b)

EEGSq

a

reversal of language patterns.
.

In all subjects there

is

desynchronization of frequencies

\

and decrease

in voltage. Alpha rhythms are less prominent.

!

low
Occasionally,
\

-—-a

c" In

voltage

“ILA

577’

frequencies appear.

\

voltages-a25of
delta
with
degrees
varying
activity,
patients

in

decrease‘, frequencies decrease and burst activity disappears. Irregular
alpha and beta frequencies of low voltage become
c)

The EEE and

persist

clinical effects consist for

gradually disappear.

one

mmminent.
to three hours, and

�Discussion:
The pharmacologic

effects of diethazine are described as "anti-

cholinergic" and "atropine-like," and in patients with altered brain

function

may be
h

described as "allert‘

electroshock induced

m

(Ulett).

EEG

delta is

P

The

action of diethazine an
0

.

scopﬂl ine
similar to atropine and eeelpalemine

(Zinc

ﬂoss observations era‘similar

to those in subjects

with head injury (Jeéhker and Lechner).
Conclusion:

‘1'“
Based on this data, as well as the cerebr¢{:§pinal ﬂuid cholin-

esterase studies of Bornstein) and

Tower and McEachern,

.

fuedJLb£1
diethazine hes-e ready

that: (l)

'

'

it

is

.:
enter the central

axrhnL;
and
trauma
induced
electroshock
by
by
delta
system3(2)
a
.

concluded
nervous

4'

may

similar
A

have

biochemical substrate;(3) electroshock may be looked upon as a controlled

6F Alana;
method tc.indnge ce ebral dysfunction for
The

its

induced behavioral

significance of these observations for

EEG

studies of head

trauma and the mode of action of gin-ilpconvulsiVe therapy

discussed.

effects.

will

be

�//—

£3th at Diethuine on 3%: and Significance for Theory at
Germanium

mm

Previous studies of the rule of
have

demtrnted

EEG

changes

in convulsive thenpy

the eigmfieam or the induced delta activity for

the behwioral response. Imeatigetions containing the

substrate of

EEG

1:10ch

delte 1n electroshock and convulsions have inﬂated

significance for the eholinestemae - mtwlchonne system.

reports

Ulatt concerning the «treats a! atropine and

by

anthedalta
patterns,

response

otheEEGshemdamml

of

napalm

theinducedm

Goncurrent reports by Jemkner and Lochner an the

ofﬂiethum «1110;14:11me

Recent.

effects

mtrmmmmmmm

atimelua for the study of the effects or this drug in electmahock.
Subagetet
Twenty

voluntary

psychiatric patimte in en upward/psychiatric hospital

have been tested

to date. Electroencephalogm have been obtained

mutant.

During the recording,

at. various

ﬁnes during

(limit)

is administer! intmemualy

per

me

until

at. the

250 Milligrams have been

rate of

Metered.

diethume

25 milligrams

a

an

�¢2~

mumations:
a.)

Behavioral

-

51].

subjects respand by coming, dryness (J the

math and thickness of speech. Feelings of weakness of extremities
and

mm.

illusory sensations are

Mamas

is

news in mt.

an

difficulty in maintaining eyes closed. In pgtients

3nd

who have had

There

Mficient ehctmhwk to manifest syntactic

and

onentation language changes indicative of altamd cerebral function,
them in a reversal of language pattern»
b)

EEG

~

In all subjects than

in Voltage.

and decrease

Damionﬂly,

10w

is «synchronization

Alpha

W

of Inqueneies

are less prominent.

tnqmncies appear.

voltnga

In pstinnta with varying dogma of delta activity, voltaga is

deemed, tmquemiea

in

“cram am}

burst wtivity disappears; Irregular

alpha and but: fmqmnoioa of law voltage become more
a) Tho

W

and

liy

clinical eﬂwta

diuppnr.

.

pox-stat

mm

gamut.

for om to than hours, and

�A!

mammalian
The phnmaeolog'ic

effects of diethuine are described as ”anti-

cholinergia“ and “atmpimlﬂm,” and in patients with altered brain

function

may be

doacribod an ”martini." The action of

electroshock induced

(Butt).

EEG

delta is 3min:- to atropine

Also, than. observations

with hast!

11131211

(«bunker and

m

diothum

8nd

n

W
napalm

51:11” to than in subdue“

Mr).

091191113th

Band on this data, us

all

0

as the carom spinal ﬂuid wanna

«tea-am swarms of Bernstein and

Tower and IicEnchem,

it is minded

that: (1) diothuine has a randy ability to enter the central nervous
system (2) delta induud by electroshock and by trauma my have similar

Mommioal substrate (3) electroshock my be loolwd upon as a controlled
m’chod

to induce cerebral dysfunction for

Ema

tm

its

induced behavim'al effects.

hand
for'EEG
of
atxﬁias
of
these
obsamtiona
significant:

and the mode of

discussed.

act-.1031

of electmcomluvo therapy will. be

�MM

or

blow

swam

m

and
Gmmlaim Therapy
on

m m,

for

1119on

of

24.13.

me changes in wmulsive therapy
have
the signifiam of the induced delta actdxiw for
the
biochemm
umoarning
the
Invasﬁgatlans
tome.
have
EEG
and
indicated
electroshock
emulsions
of
delta
in
mutate
nignﬁmm tor the ahonmuem - mmdcholine system mm.
Pruvioua studies

Wand
1:6de

at the rails

of.

otatropdmandaoopolmo
Wbymttcommmgmeﬂw
EEG
induced
showed
EEG
or
cloctrashook
a moral
in
an
pattom.
am:
Comm-rent reparts by Janka»: and Lechner an the: extent: of
on mm]. EEG and that. following tram provided this stimulus far the
study of the effects at this drug in electroshock.

mm

Salaam”
treatment
various
during
ht
stages
patina“
puma-lo
in an open—ward voluntary psychiatric hospital have been tested to
(Dimmol) is manicured
date. "During EEG recording,
int-.mwaly at the rate of 25 milligrams- por minute, for a total
at 2%
Twenty

diam

W0
Mmtionu

'

:

a)

%:

b)

m
m

All subjects respond by coughing, dryness of the
thickness of mach. Feelings of weakness of emu-mitten
mm
and illusory marathons are cam. more is an immune 1h restless.
mas and mamty 1n maintaimng eyes clued. In patients who
have had sufficient. electroshock to manila“ syntactic and orientation
language changes indicative of album earabral function, there is a
reversal of language patterns.

more 13a doaynchrmiuuon of rmmdes
down» in voltage. Alpha rhythms are less lament.
Occasionally, 1m? voltage theta frequencies appear.
In

all subjects

In patients with varying demos of delta activity, voltageand
burnt
increase
frequencies
activity disappears. Irregular
decmo,
alpha and beta Imumcies of low voltage become prominent.
c) The EEG and clinical effects persist for one to three hours, and
gradually disappear.

Fm

Department of
men Oaks, ELY.
than

1.1-6.5?

-

EAEEG

mmm

Psychiatry, Hillside Hospital,

�‘5

of
downbeat
aﬂoat:
dawn»
m
Wohgie
u
”antiwhonmtgie" and 'ttropine‘uka," and in patina“ With slated
brain imam any be 6030de as ”wrung.” the mum at
on ahctroshack induced EEG delta is amm to atropine
610mm
um! £39me (010%). mm ebmmﬁom an aim similar to
ﬁrm in aubjccta with bud injury (Janina: and helmet).
The

cmcluaiam
Mac! on this duh, as «11 as this cerebmspinal fluid
cholimatamso studios of Ben-MW, and Tower and Wuhan,
is wmludod that: (1) damn» mam entm the «antral
nervous system; (2) delta nativity inducod kw alwtrodmck and
and
by tram may ham: 3 similar
(3)
mutate:
mm be lookad upon an o. watt-0119c! ”that! of naming «mural
to: its behaviaral affaa‘w.

it

mmwu

m
Wanna
The

«:1ng
the
or action of convulsive: therapy will

trauma and

node

of

thew

than mamtiom for m ”adieu or had
be

animated.

�v

-r:‘V?\'(‘r.uv'

w--w—ILW|&gt;L‘»V‘V'~B—w"y:mm w—r-mw-vwn»vww.,u—A » v —.-.r. -- .vr.

w—y

~

w

—

"av/\—

&lt;7

r

,rw-I'IWK

.

aw

u

'mwl'

-

-

-

"a.“

AM'HV'Wwv _,,,

A

was

�wan-my

r'm

��Form 90-Adm.

éhhft$nk jﬂuh

ﬁsgrlﬁatrit gustitute
722 WEST 188'"! STREET.
LAWRENCE B. KDLI, M. D.

nlnlm'run

NEW YORK

December 4, 1957

Dr. Max Fink
Dept. of Experimental PSychiatry
Hillside Hospital
75—59 263rd Street
Glen Oaks, New York
Dear Max:

feelings about Saturday night are reciprocal.
Weihoroughly enjoyed the gracious company of you and
Martha. With the intuitive perceptiveness of the female, Yetta informed me of a forthcoming event in your
family, and we Wish you the best of everything.
I indeed look forward to the reprints on your Work
which you described in your letter and our discussing
them together. The next edition of the Kalinowsky and
Hoch will be expanded to include tranquilizers, and I
would also appreciate any reprints of yours in this area.
I have enclosed my own reprint on the clinical
effects of Win-2299 and the basic paper by Luduena
and Lands. As you will note, the compound is a peripheral anticholinergic and produces a "disorientative"
reaction in cats by central action. Its psychotomimetic
action in man appears basically to be an acute toxic
reaction type. I would imagine that its central mech~
anism of action is similar to that of atropine (which
also produces acute confusional states in high doses).
Win—2299 is effective at much lower dosages than atro—
pine. Possibly both atropine and Win—2299 both produce
central effects by an anticholinergic action but, as
far as I know, this modus operandi has not been pinned
down crucially as far as the C.N.S. is concerned.
I would not expect all anticholinergic agents to be
psychotomimetic, of course. Win-2299 is a tertiary
amine. Monodral is a closely related drug, differing
only by quaternization of the terminal nitrogen in
Win—2299. It is Win~4369 in the paper of Luduena and
Lands (p.283), i.e. the methobromide form. According
to Winthrop-Sterling, it is a peripheral anticholinergic
in man in doses of 5-40 mg. per day. Central or psychic
actions are not mentioned in their account. Presumably,
quaternization reduces central activity by reducing
permeability.
Our

�Dr.

Max

Fink (cont'd)

’

-2—

I imagine that other agents in the Win series with
central effects in cats might also be active as psychotomimetics in man. I am not familiar with the formula
of diparcol and if you have it available would appreciate
learning where to look it up. The drug is not covered
by Goodman and Gilman. I would appreciate return of the
Luduena and Lands paper when it has served your needs.
We

gave the Win—2299

the
orally,
The

compound being
drug was supplied as the

supplied in tablet form.
racemic mixture, the asymmetric carbon atom being terminal in the aliphatic chain. Sterling—Winthrop may
have it for intravenous use and I suggest that you write
M. L. Tainter, M.D., Director, Sterling-Winthrop Research Institute, Rensselaer, N.Y. about it. Our oral
supply was used up in the study.
As you know, all psychotomimetics not only create
new symptoms in mental patients but also intensify or
revive pre-existent symptoms.
Best of luck.

Cordially,

”2a
Harry
Pennes,
H.

HHP/ys

Encl.

M.D.

�PA

if

..
_

*

(on

1M5?

I

Effect of Diethazine

on EEG and

we

Significance for Theory of Convulsh

M

Therapy

MD
Mow
In a previous report to-this society we noted the relationship between
the degree of induced delta activity during the course of therapy and the
behavioral reSponse to electroshock. Those patients, in

delta activity were induced early,

and were

degrees of behavioral change, as well as a

significantly greater percentage

W
gm

vial

£64414a

Law In.

Box}

EH:

acetylcholine

and

in

whom

only low degrees

were induced (Fink and Kahn, 1957).

activity

1,

(ii;

'1.)

high degrees of

sustained, manifested the greatest

of improvement and recovery than those patients
of delta

whom

,hML-wQA‘O‘
. a, W"
,
‘Jawc‘z
MM
L

Mkﬁl‘g‘f‘” ’M‘Af‘z‘ mv’efrff
"
in!“
(.4

Mﬁanges infree”
'

a variety é‘fu‘reports,

cholinesterase in the Spinal fluids of patients (Sachs,
9.

Ward) and animals (Bdrnstein, Tower and McEachern) following head

Wig;
.

.

I

the observations that
by trauma

M

o

(Bfrnstein,

ﬂue/4%

In

1956

.c‘

E

agents liq—alter the

EEG

patterns induced

Ward, Jenkner-Lechner) and by electroshock

(

“knew“at?mp

(Ulett)pu_l

Ulett reported that atropine g’scbpolaminerwhea-aéiénéstered—

/

W,

blocked the appearance of the delta

wea»...have
come to associate with
- _,-.,..«-'V'F-r -v~ WWW ahaaul,” "‘4“qu

w.

traumalawﬂ

electroshock therapy.

A!” 791’]
am’LlLJ/g/J
M ’L “‘2‘“ 4“““4/ié’MWrrW ”“an“
j?”

activity

{lama/Wye?

v»

�-ebeervetions~ Previously, ward (193) following the suggestion of Bornsteiny
(19h6) had noted

that atropine altered both the

EEG

patterns

and the

neurologic signs induced in.man by head trauma. aﬁereT-tee, the side
ZZ,AQA7V

~effects were marked. In 1955: Jenkner and Lechner reported that

EEG

behavioral effects similar to atropine were achieved by diethazine

istered in patients with head trauma.‘

They

and

admin—

also reported the effect‘of

diethazine in normal subjects.

It is

the purpose of this report to describe the effects of intravenous

diethazine on the

EEG

of patients during electroshock therapy; and to

relate their these findings to the present neurophysiologic-adaptive
hypothesis of the ndde of~action of convulsive therapy.
w

‘ﬂwmwmﬂmwwwﬂ_ﬂ____.imm

3"

Diethazine is a soluble phenothiazine

compound

with phamacologic

properties similar to atropine. In experimental animals,
(19h?) have noted

that diethazine blocks vagal slowing of the heart‘)

M

suppresses the bradycardia, bronchospasm, salivation, and fasciculation
and

seizures induced

by

acetylcholine,

DFP

‘‘‘‘‘ ‘wywwﬂﬁmgimww‘ﬁzoxsum-“:- w'

”mm—«MA..-

and pilocaxxﬁxg and induces

dry mouth, mydriasis and hypotension.

L/——'

/

Heymans EE.E£

a“: nevus-aw» 4.: '2‘ YW',‘47"’~"5‘W1‘-05 Emma-gwhz

-

.—

'

.~_4~:_MD~J

�93"

”w

W

Subjects: Twenty-two

psychiatric

42‘

patients,” various

stages of electro-

shock treatment in an open-ward, voluntary psychiatric hOSpital have been

studied.
the

laboratory. Following a routine

EEG

administered intravenously at the rate of
of

2630

to 250

mgm,

the

i
Tl’br.‘

EEG

25 mgm

per minute, for a

total

effects. Prior to the

historical interview and a structured

questionnaire period were tape-recorded.
EEG

recording, diethazine was

depending upon the behavioral

drug administration, an unstructured

both

EEG

gubjects were tested in

Following drug administration,

recording‘ and recorded interview periods were continued until
record again manifested.the pre-injection patterns on visual

inspection.
Mm New.

‘&gt;IIVW~..

Qbservations:

in Le

,,

(a) Clinical: AH su jects manifesm Spontaneous coughing mutual-i33-

@

followed by a dryness of the mouth and a thickness of speech.
ﬂgrtrf

They

note‘,

'
3'37

a feeling of lassitude and weakness of the extremities? soon followed by

increased restlessness and difficulty in maintaining eyelid closure.
phenomena were

PSymW/clearly

between 15 and 30 minutes

.

manifested in

after

some

subjects. In the rest period

drug administration, six subjects spontan-

..,. _‘ ...

_

A

�4,.
eously voiced feelings of unreality, visual and haptic illusions, and

delusional thoughts about their illness, the setting of the test procedures or our

identity.

Such

patterns

were

transient

and had disappeared

In

by the termination of the experiment,-asaallyhiééﬁﬁurdﬁnnxrdnmzns.

three subjects, increasing agitation
.

and panic led to a cessaﬁon of

the recording. éHere7-tccy—restétation_a£—pme—énjenﬁﬁnnrdnﬁuuﬁuuaauua
I

'li'
g“,

,

I!

i

.

ﬁilliwuwﬁ

(b) In previous studies,

the intimate relationship

we had noted

between changes in syntactic language patterns with

alteration in cerebral

function induced by electroshock. In subjects tested prior to electroshock,
diethazine induced changes in syntactic pattern of an "alerting" variety.
I

-

gal

[5%
In subjects with elta activity‘ with clinical syntactic patterns indicative

of an

alteration in cerebral function, diethazine induced a transient dis-

appearance or minimzation of Such language

in language
(c)

was concurrent with changes

EEG

Patterns: In

all

patterns.

The

period of changes

in electroencephalogram.

records, there is a decrease in voltage and

desynchronization of frequencies. There

is

a decrease in prominence of

prevailing rhythms. In patients without delta activity (pre-electrodhock)’

�-s5‘ 4/

this deéhronization

and voltage decrease

is

occasionally accompanied

by the appearance of small amounts of low voltage
These

are demonstrated in Slides 1,

not appear to be altered.

The

and 2.

The

5’7

'5' cps activity.

basic alpha rate does

build-up in voltages and appearance of

thm

slower frequencies with hyperventilation is blocked.

In patients with varying degrees of induced high voltage

activity

voltage”, both

random and

4

This change

It

and

3

dub

is a decrease in

burst delta activity disappears; and irregular,
/

low voltage alpha and beta frequencies become prominent.

are noted in Slides

delta

These changes

LL.

5W

in

is

manifest in

appears during drug administration, and

all

electroshock subjects.

persists for

awe. [WM
ﬁlwwx
13%
2/1.
ﬂoncurren WithAelectroencephalographic
hours

vtwv
‘

”fly
to three
age

MM»

Wrens-em

ﬁith the

8&amp;3 17TH 770 n

moustita—tion—

of the pre-injectionEl'I} patterns, the pre-injection behavioral and
language patterns again appeared.

�DISCUSSION:

report of Jenkner and Lechner of the
t”t.¥£~£ dikd/“4lz‘ijzz7'
effects of diethazine in"normal" subjects. 'Wa.alsa—nnta_tha§21iethazine
These observations confirm the

alters records-snd-ﬁith electroshock induced delta activity in‘a fashion
similar to atropine

and scopolamine, as described by

Ulett,

A Mada»
W
was.
.

1%,.

is apparent, therefore, thatngﬁ readily affects the central nervous
and.é53 duration

system,

ofiactivity is most useful for experimental purposes.

The-previeusiy—eitnd studies by numerous Observers of nervous system

effects of head trauma point to

an intimate

relationship between the degree

of neurologic dysfunction, the degree of

EEG

alterationjgand the level of

free acetylcholine in the spinal fluid.

The

effect of atropine both

the Echand

ill

on

concomitantly on behavior in subjects with head trauma lends

further support to the significance of ﬁgs: acetylcholine as the biochemical
basis for the observed

EEG

patterns.

In these studies of diethazine

electroshock, the intimate relationship between

EEG

patterns

and

and behavior

�-7have been reported.

We

note the parallel to the observations in head

\

trauma.

On

the basﬁs of these observations, as well as studies of Spinal

fluid

Woholinesterase levels; (Tower
we would

and HoEachern, Fink and Goldenberg)‘

suggest that the biochemical substrate of the electroshock process.

is isimilar to that of head
controlled

trauma.9

method of inducing

ectroshock
hLauri.

may be looked upon

cerebral dysfunction for

its

as a

behavioral

effects.
Previous studies have demonstrated

that alteration in cerebral function

provides the physiologic basis for the behavioral changes in electroshock
(Fink and Kahn, 1957).

Such

alteration in cerebral function provides the

milieu for a change in the organism's adaptation to his environment.
aSpects of behavior, as perception, language,

mood,

recall,

memory,

All

affect,

undergo change, and provide the basis for the

therapist's evaluation

of improvement. The studies of diethazine amplify

this neurophysiologic

9.39.9.

adaptive hypothesis of electroshock by suggesting the type of biochemical

substrate that underlies both the physiologic

and the behavioral changes.

�Mm=
0

Diethazine, a pftent anti-cholinergic compound,

u

was

experimentally

introduced intravenously in psychiatric subjects,;ﬁ various stages of
convulsive therapy.
Electroencephalograms manifested a desynchmnization of frequenciesfue («C

decrease in voltage
records without prior delta activity.

Records with

delta activity

showed

similar changes with disappearance of delta burst activity.
Concomitant with the electrographic

patterns indicative of

It is

concluded

a

effects, behavioral

reversal of the electroshock effect

enters the central nervous

System upon intravenous

(b) The biodemical basis for

that of head trauma;
(c)

therapy

The
may

EEG

compound

that readily

adninistration.

changes in electroshock

is similar

and

biochemical basis of the

lie in

were observed.

that:

(a) Diethazine is a Bitent anti-cholinergic

to

and language

mode

of action of convulsive

the acetylcholine-cholinesterase system.

a,

�@

Research and Development Division

SMITH, KLINE

&amp;

FRENCH LABORATORIES

PHILADELPHIA

-

I

ESTABLISHED I84|

December 11, 1956

Max

Fink, M.D.

Director of Research
Hillside Hospital
75—59

263rd

Glen Oaks,

Street

New York

Dear Doctor Fink:

associate, Mr. C. W, French, has referred your letter of November 12
requesting a supply of diethazine to me for reply. It has taken me a
little While to uncover-sufficient supplies for the short clinical trial
you want to conduct since our interest in diethazine alone and in come
bination with 'Thorazine' isn't too great at this time.
My

not have this compound available in 500 mg. capsules as you requested. It is only available in 250 mg. tablets. A supply of this
strength has been sent to you together with a supply of the intravenous

we do

material so that you

is all the literature we
this will be of some help.

Enclosed
hope

the

may Observe

EEG

effects

on 10

have available on

Sincerely yours,
.\

to

15

patients.

diethazine. I

,

J”,
Meagan?
Ms
(,7

.

John F. Buckley
a Research
Associate

/

’

'

Medical Department

JFB:hc

Enclosures

P.S. Will you kindly sign the enclosed FDA card and return
so that we may keep our files up-to-date.

it

to us

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="2">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="2">
                <text>Published Works</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <itemType itemTypeId="1">
    <name>Text</name>
    <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
  </itemType>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2564">
              <text>Effects of Diethazine on EEG and significance for theory of convulsive therapy. Electroencephalogr Clin Neurophysiol. 10 207-208. (abstract).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2565">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="2566">
              <text>mfp-02-01-002-29a-004</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2567">
              <text>1958</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2568">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2569">
              <text>Published Works -- Articles and Reviews</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="2570">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2571">
              <text>13 items. 1: Handwritten notes. 2: Clinical Release. 3: Diparcol. 4: Pharmacology Report. 5: Letter to Fink from R. S. Griffith. 6: Letter to Fink from Herman C. B. Denber. 7: Letter to Denber from Fink. 8: Draft with edits. 9: Two drafts. 10: Handwritten notes. 11: Letter to Fink from Harry H. Pennes. 12: Draft with edits. 13: Letter to Fink from John F. Buckley</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="2572">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="2573">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="74459">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="81020">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="87581">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="94142">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="5">
      <name>Published</name>
    </tag>
  </tagContainer>
</item>
